Pharmabiz

RDCA asks members to prepare their technical infrastructure for complying DCA mandate on controlled drugs

RDCA asks members to prepare their technical infrastructure for complying DCA mandate on controlled drugs: Peethaambaran ...
Pharmabiz

NewBiologix and Synastra Biotechnology partner to advance stable rAAV manufacturing for Duchenne muscular dystrophy gene therapy

NewBiologix and Synastra Biotechnology partner to advance stable rAAV manufacturing for Duchenne muscular dystrophy gene therapy: Lausanne, Switzerland Thursday, September 3, 2026 ...
Pharmabiz

Indian lifesciences sees AI as indispensable as it propels innovation from drug discovery to patient care

Indian lifesciences sees AI as indispensable as it propels innovation from drug discovery to patient care: Nandita Vijayasimha, Bengaluru Thursday, September 3, 2026, 08:00 Hrs [I ...
Pharmabiz

PCI warns of action against attempts to create duplicate or fictitious profiles in DIGI-Pharmed

The Pharmacy Council of India (PCI) has warned of strict legal and disciplinary action against any attempt to create, maintain or use duplicate or fictitious profiles or fake faculty credentials of ...
Pharmabiz

National Pharmacovigilance Week 2026 to focus on rational use of medicines & patient safety

National Pharmacovigilance Week 2026 to focus on rational use of medicines & patient safety: Peethaambaran Kunnathoor, Chennai Thursday, September 3, 2026, 08:00 Hrs [IST] The Ind ...
Pharmabiz

CDSCO cancels registration of cosmetic products importer for alleged violation of rules

CDSCO cancels registration of cosmetic products importer for alleged violation of rules: Gireesh Babu, New Delhi Thursday, September 3, 2026, 08:00 Hrs [IST] The Central Drugs Sta ...
Pharmabiz

AIG Hospitals lays foundation stone for new multispeciality hospital in Visakhapatnam

AIG Hospitals laid the foundation stone for a new, greenfield multispeciality hospital in Visakhapatnam, to be operational by ...
Pharmabiz

Novartis remibrutinib, a high-efficacy oral BTK inhibitor, significantly reduces relapse rates and shows favourable safety profile in phase III RMS trials

Novartis remibrutinib, a high-efficacy oral BTK inhibitor, significantly reduces relapse rates and shows favourable safety ...
Pharmabiz

Hutchmed announces SANOVO phase III clinical trial, showing significant progression-free survival benefit of Orpathys plus Tagrisso

Hutchmed announces SANOVO phase III clinical trial, showing significant progression-free survival benefit of Orpathys plus Tagrisso: Hong Kong, Shanghai Wednesday, September 2, 20 ...
Pharmabiz

DEKA’s ONDA PRO with patented Coolwaves technology for aesthetic medicine launched at Dr Rashmi Shetty’s clinic in Mumbai

DEKA’s ONDA PRO with patented Coolwaves technology for aesthetic medicine launched at Dr Rashmi Shetty’s clinic in Mumbai: Our Bureau, Mumbai Wednesday, September 2, 2026, 17: ...
Pharmabiz

PTCOG-AO 2026 conference to be held in Chennai from September 4–6, 2026

PTCOG-AO 2026 conference to be held in Chennai from September 4–6, 2026: Our Bureau, Mumbai Wednesday, September 2, 2026, 15:15 Hrs [IST] More than 500 delegates from 25 countri ...
Pharmabiz

One FIP’ takes centre stage as FIP president opens 84th FIP world congress in Montreal

One FIP’ takes centre stage as FIP president opens 84th FIP world congress in Montreal: Our Bureau Bengaluru Wednesday, September 2, 2026, 14:45 Hrs [IST] Opening the 84th FIP W ...